Literature DB >> 8883559

The incidence of registered blindness caused by age-related macular degeneration.

T Rosenberg1, F Klie.   

Abstract

Membership applications to the Danish Society of the Blind were used as a register source of legal blindness (visual acuity < or = 6/60). Based on application forms completed by specialists in ophthalmology 1585 subjects were recorded as blind in 1993. 1132 subjects (71.4%) had age-related macular degeneration. Only 5% of the registered subjects with age-related macular degeneration were below 70 years of age. The median age was 82, equal for both gender. A female overrepresentation of 2.8:1 was found. Five-year age-specific incidence rates demonstrated an exponential rise of registered blindness due to age-related macular degeneration from age 60 to 90. A decline in incidence after the age of 90 is assumed to reflect underregistration of very old persons. This tendency of non-registration was particularly pronounced in elderly males. Estimated prevalence rates of registered blindness due to age-related macular degeneration increased 100-fold from the age group 60-64 to the age group 80-84. The age specific incidence rate for the age group 60-99 years was 140:100,000 for females and only 66:100,000 for males. The corresponding incidence rate for both sexes was 108:100,000. It is still a matter of dispute whether 'true' prevalence rates of blindness are higher in females than in males. The sex difference seems not to be explained by differences in 'visual impairment threshold of registration' among the registered persons.

Entities:  

Mesh:

Year:  1996        PMID: 8883559     DOI: 10.1111/j.1600-0420.1996.tb00717.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN: 1395-3907


  8 in total

Review 1.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

2.  The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study.

Authors:  Jie Jin Wang; Robert J Ross; Jingsheng Tuo; George Burlutsky; Ava G Tan; Chi-Chao Chan; Emmanuel J Favaloro; Andrew Williams; Paul Mitchell
Journal:  Ophthalmology       Date:  2007-08-02       Impact factor: 12.079

3.  High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture.

Authors:  B Y Ishida; K G Duncan; K R Bailey; J P Kane; D M Schwartz
Journal:  Br J Ophthalmol       Date:  2006-05       Impact factor: 4.638

Review 4.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Prevalence and the risk factors for visual impairment in age-related macular degeneration.

Authors:  S Srinivasan; G Swaminathan; V Kulothungan; R Raman; T Sharma
Journal:  Eye (Lond)       Date:  2017-05-26       Impact factor: 3.775

Review 6.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

7.  Age-Related Macular Degeneration Is Associated with Less Physical Activity among US Adults: Cross-Sectional Study.

Authors:  Paul D Loprinzi; Bonnielin K Swenor; Pradeep Y Ramulu
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

Review 8.  Genetic basis of inherited macular dystrophies and implications for stem cell therapy.

Authors:  Carla B Mellough; David H W Steel; Majlinda Lako
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.